06:47:36 Europe / Stockholm
Svenska | English

CS Medica

Attachments

Share price & Turnover

Share price change and turnover during the day of this press release

Calendar

2024-12-17 Annual General meeting
2024-11-14 Year-end Report 2024
2024-08-15 Quarterly Report 2024-Q3
2024-07-31 Extra General Meeting 2024
2024-05-30 Annual General meeting
2024-05-17 Quarterly Report 2024-Q2
2024-03-01 Ex-date Ordinary Dividend CSMED 0.00 DKK
2024-02-14 Year-end Report 2023
2024-02-14 Quarterly Report 2024-Q1
2023-12-15 Ex-date Ordinary Dividend CSMED 0.00 DKK
2023-07-18 Quarterly Report 2023-Q3
2023-05-17 Quarterly Report 2023-Q2
2023-04-14 Extra General Meeting 2023
2023-02-17 Quarterly Report 2023-Q1
2023-02-14 Annual General meeting
2023-02-10 Ex-date Ordinary Dividend CSMED 0.00 DKK
2022-11-18 Year-end Report 2022
2022-08-13 Quarterly Report 2022-Q3
2022-05-20 Quarterly Report 2022-Q2
2022-02-18 Quarterly Report 2022-Q1
2021-12-10 Ex-date Ordinary Dividend CSMED 0.00 DKK
2021-12-09 Annual General meeting
2021-11-18 Year-end Report 2021

Description

CountryDenmark
ListSpotlight DK
SectorHealth care
IndustryDrugs & Trade
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
CS MEDICA A/S invites to a live-streamed Status Event on August 16 at 16:00 CEST
2022-08-15 09:40:13

CS MEDICA A/S ("CS MEDICA" or the "Company") announces today that the company invites investors, brokers, analysts, and media to a live-streamed Event with a subsequent question and answer session on August 16 at 16:00 CEST.

CS MEDICA will shortly present top-line status within clinical trials, sales & growth, product pipeline, the liquidity situation, and current Investment opportunities. The purpose of the event is to provide investors, analysts, and media with a better understanding of the current situation in CS MEDICA. The event will be held in English.

Agenda for the Event
  • CEO Comments

- Consolidation
- Organization

  • MDR Plan Science and clinical trials
- Product pipeline
- First mover advantages
  • Marketing branding, status and growth
  • Presentation of sales strategy and pipeline
  • Investment and Funding
  • Q&A-session
Questions can be asked prior to the event by sending an email to info@cs-medica.comor during the webcast via a chat function. The webcast will also be available on demand on CS-MEDICA's corporate website (https://www.cs-medica.com/) after the event.

Date and time
August 16, 2022, from 16:00-17:30 p.m. CEST

Webcast link
Registration for event >> (https://www.cannasen.dk/investorcall)
Live Webcast link >> (https://teams.microsoft.com/l/meetup-join/19%3ameeting_NWE5MDkxMTUtZmVjOS00ZWNlLTg5OWItNWVlMzBhMmI1Mjlh%40thread.v2/0?context=%7b%22Tid%22%3a%2203c789ea-e1f1-4d23-81be-21027376e496%22%2c%22Oid%22%3a%224ab51ce2-2530-4826-866b-2cc0ef5e8411%22%7d).

Introducing the speakers

[image]

For more information about CS MEDICA, please contact:

Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/

Source Cision
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

An email has been sent to the given address. To login please click "Login" in that email to verify your account

Companies

Press releases